Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2008 Nov 5;47(1):275–277. doi: 10.1128/JCM.01630-08

Lactobacillus delbrueckii as the Cause of Urinary Tract Infection

Benjamin W Darbro 1, Brian K Petroelje 1, Gary V Doern 1,*
PMCID: PMC2620876  PMID: 18987176

Abstract

Lactobacilli are part of the normal bacterial flora of the vagina and are typically considered contaminants when cultured from urine specimens of female patients. Here we describe the case of a female patient with chronic pyuria and urinary tract symptoms in which Lactobacillus delbrueckii was determined to be the causative microorganism.

CASE REPORT

An 85-year-old female with recurrent urinary tract infections called her gynecologist reporting painful urination, frequency, and urgency. A prescription for ciprofloxacin at 250 mg twice a day (BID) for 7 days (adjusted for a decreased glomerular filtration rate) was called in to her local pharmacy. She experienced no relief of symptoms with this treatment.

Two weeks later, she was seen in the clinic. She denied fevers or flank pain but continued to have urgency, dysuria, and a frequency of every 1.5 h, including nocturia. Her further pertinent medical and surgical history included a stage III cystocele, vaginal prolapse repair in 1999, total abdominal hysterectomy with bilateral salpingoopherectomy in 1962, hypothyroidism, and two prior discectomies. She intermittently applied vaginal estradiol. She had not used pessaries for her vaginal prolapse in 9 years and had no recent indwelling Foley catheter or intermittent self-catheterization. Examination revealed inflamed labia minora. The postvoiding residual was 100 ml. A straight catheter sample was obtained for culture and due to well-documented allergies to penicillin, sulfa, and nitrofurantoin, another course of ciprofloxacin was prescribed (250 mg BID for 10 days). Nystatin-triamcinolone ointment and zinc oxide were prescribed for the perivulvar dermatitis. Urine culture yielded >50,000 CFU/ml of a microaerophilic, alpha-hemolytic, gram-positive bacillus that was both catalase and oxidase negative. In view of these characteristics together with a very characteristic Gram stain morphology, the organism was presumptively identified as a Lactobacillus species and was judged to be a contaminant.

The nocturia, frequency, and dysuria did not resolve, and she returned 6 weeks later. She described a postvoiding sensation of “sand in my bladder.” No systemic symptoms occurred in the interval. An examination showed improved but residual erythema and mild edema of the labia minora and introitus. The vaginal epithelium was intact with mild erythema suggesting atrophy. A straight catheter urine sample was obtained, and the patient was given another course of ciprofloxacin for 10 days. Urine microscopy showed significant pyuria with white blood cell (WBC) clumps and many bacteria, and culture again yielded >50,000 CFU/ml of a Lactobacillus sp., which was again considered to be a contaminant.

After no improvement following the third course of ciprofloxacin treatment, an infectious disease consult was obtained. Urine studies were repeated. Again, urine microscopy showed significant pyuria, WBC clumping, and many bacteria, and culture grew >50,000 CFU/ml of a Lactobacillus species. Etest MICs determined on Mueller-Hinton agar incubated anaerobically were as follows: doxycycline, 0.5 μg/ml; ampicillin, 0.25 μg/ml; erythromycin, ≤0.03 μg/ml; vancomycin, 0.5 μg/ml; linezolid, 1 μg/ml; moxifloxacin, 1 μg/ml; ciprofloxacin, >32 μg/ml. Bacterial 16S rRNA gene sequencing was performed by our institution's molecular pathology laboratory with the MicroSeq 500 16S rRNA gene bacterial identification sequencing kit and a 3130 Genetic Analyzer (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions. The sequence data obtained were then compared with known 16S rRNA gene sequences in the GenBank database by BLAST search. Greater than 99.0% identity between the isolate and database sequence was required for identification at both the genus and species levels (with greater than 0.8% separation between different species) (2). Analysis of the isolate's 16S rRNA gene sequence revealed it to be Lactobacillus delbrueckii (6).

Based on susceptibility test results and documented allergies, the patient was prescribed a 2-week course of clarithromycin therapy at 250 mg BID, with resolution of her urgency and dysuria and marked improvement of her urinary frequency. Urine studies following the end of therapy showed a significant reduction in the number of urine WBCs (Table 1). A leukocyte esterase test was negative, as was a straight catheter urine culture.

TABLE 1.

Profile of urine studies and culturesh

Date Collection method No. of WBCs/HPFf in urine No. of squamous cells/LPFg Culture result (CFU/ml)
Current urine studies
    7/02/08a Straight catheter 22 9 Negative
    6/24/08a Straight catheter 23 0 Negative
    6/9/08 Straight catheter 155 0 >50,000, Lactobacillus sp.e
    5/29/08 Straight catheter 180 0 >50,000, Lactobacillus sp.
    4/14/08 Straight catheter NDb ND >50,000, Lactobacillus sp.
Prior urine studies
    2/1/08 Straight catheter 45 10 3,000, Lactobacillus sp.
    1/7/08 MSCCc 180 96 >50,000, Klebsiella pneumoniae
    11/29/07 Straight catheter ND ND >50,000, Enterococcus sp.; >50,000, Candida albicans
    10/25/07 MSCC 10-25 1-10 Negative
    7/31/07 MSCC 10-25 >30 >50,000, Lactobacillus sp.
    2/28/06 Straight catheter ND ND >50,000, Lactobacillus sp.; 100, coagulase-negative Staphylococcus
    12/6/05 MSCC 0-2 <1 Negative
    3/1/05 MSCC 2-5 <1 >50,000, Lactobacillus sp.
    11/16/04 MSCC TNTCd 10-20 >50,000, Escherichia coli
    4/20/04 MSCC ND ND Negative
    9/13/02 MSCC 25-50 >30 >50,000, Lactobacillus sp.
a

Posttreatment with clarithromycin.

b

ND, not done.

c

MSCC, midstream clean catch.

d

TNTC, too numerous to count.

e

16S rRNA gene sequencing revealed this isolate to be L. delbrueckii.

f

HPF, high-power field.

g

LPF, low-power field.

h

Unclean samples with numerous mixed organisms not reported.

A retroperitoneal ultrasound showed mild cortical thinning of the kidneys secondary to prior reflux, chronic infection, or medical renal disease. There was no evidence of hydronephrosis or stones. There was a partially exophytic, isoechoic mass at the junction of the mid zone and inferior pole of the left kidney measuring approximately 3.4 by 2.6 by 3.7 cm, which partially indented into the renal sinus. Subsequent abdominopelvic magnetic resonance imaging studies revealed multiple peripelvic simple cysts in the bilateral kidneys without solid or enhancing lesions, several areas of cortical thinning in both kidneys, no evidence for hydronephrosis or hydroureter, a nonocclusive clot in the celiac artery, and a small lesion indicating indentation of focal fat into the pancreatic tail. Follow-up cystoscopy found an erythematous urethra without lesions, squamous metaplasia of the trigone, efflux of clear urine from both ureteral orifices, the previously documented cystocele, and an area of mild erythema on the right bladder sidewall but no discrete lesions, polyps, stones, or sutures. Urine cytology was negative for any tumor cells.

Lactobacilli are part of the normal bacterial flora of the human vagina, gastrointestinal tract, and oropharynx. They are non-spore-forming, gram-positive bacilli that produce lactic acid from glucose fermentation. Most species of lactobacilli are facultatively anaerobic or microaerophilic and are typically catalase and oxidase negative. Lactobacilli also do not produce H2S or reduce nitrate to nitrite (8, 11).

Lactobacilli are generally considered to be of low virulence, rarely causing infection in humans. Lactobacillus sp. bacteremia has been described primarily in immunocompromised patients following dental manipulations, oral trauma, or endoscopic procedures and as a result of both gastrointestinal tract fistulas and gynecologic neoplasms (1, 11). Subsequent development of endocarditis has been observed in bacteremic patients with preexisting valvular defects (1, 11). Lactobacilli have also been shown to cause neonatal meningitis after vertical transmission of organisms from mother to infant during birth (11).

Urinary tract infections caused by Lactobacillus spp. are exceedingly uncommon. Our review of the literature revealed only one previously published case report of a 66-year-old diabetic male who developed acute renal failure and sepsis in a setting of ureteral obstruction. The patient's urine and blood yielded pure cultures of Lactobacillus gasseri, and following treatment with amoxicillin, the patient recovered fully (3).

Indeed, in the genitourinary tract, vaginal colonization with lactobacilli provides a natural, nonspecific defense mechanism against infection. Lactic acid production results in a lowering of the regional pH which, when combined with hydrogen peroxide production by commensal anaerobic bacteria, interferes with colonization of the vaginal mucosa by potentially uropathogenic bacteria. Lactobacilli also interfere with the adherence of would-be pathogens by production of biosurfactants such as surlactin and other antiadhesive, surface-active proteins (5, 10, 11). Because of these properties, lactobacilli are employed in probiotic preparations, the use of which is thought by some to represent an effective approach to preventing and even treating urinary tract infections (5, 9). Notwithstanding the relatively common use of Lactobacillus spp. in probiotic applications, an increase in secondary infections due to lactobacilli has not been definitively demonstrated (1, 11).

The evidence for L. delbrueckii being the cause of urinary tract infection in the patient described herein is convincing. As shown in Table 1, a Lactobacillus sp. was recovered repeatedly in significant quantities, usually in pure culture, from both midstream voided and straight catheter urine specimens from our patient over a 6-month period of time during which she remained nearly constantly symptomatic. Significant pyuria also persisted over this time. On three occasions during this interval, she received a course of therapy with ciprofloxacin and the therapy failed. Her isolate of L. delbrueckii was found to be high-level resistant to ciprofloxacin. When finally treated with clarithromycin, an antimicrobial agent to which her isolate was susceptible, she promptly responded to therapy. Follow-up urine cultures were negative, and her pyuria cleared. During the 2 months since the resolution of her symptoms, her infection has not recurred. In addition, numerous urine nitrite tests performed during the period our patient was symptomatic were all negative despite persistent pyuria. Lactobacillus does not reduce nitrate. Finally, several urine specimens obtained from our patient while she was symptomatic were found to be markedly acidic (pH = 5.0). Lactobacillus is an acid-producing bacterium.

We are confident that the extensive culture work-up of our patient excluded other typical bacterial uropathogens as a cause of her disease. We cannot completely exclude organisms such as Mycoplasma hominis or Ureaplasma urealyticum as being responsible for her symptoms; however, infection due to either of these organisms would have been expected to respond to ciprofloxacin treatment. As noted above, our patient received three courses of ciprofloxacin therapy with absolutely no resolution of her symptoms.

The pathogenesis of infection in our patient is obscure. One intriguing possibility was that our patient acquired her infecting strain of L. delbrueckii through prior use of probiotic preparations; however, she denied any history of probiotic administration. L. delbrueckii is commonly used in the preparation of numerous dairy food products, primarily yogurts and cheeses (8, 11). A second possibility is that our patient first developed vaginal colonization with L. delbrueckii as a consequence of acquiring this organism from ingested foods. She then went on to develop persistent infection with this relatively avirulent bacterium as a consequence of all of the antecedent pathology present in her genitourinary tract, which could predispose to urinary tract infection.

Recently, Imirzalioglu and colleagues used denaturing high-performance liquid chromatography analysis combined with 16S rRNA gene sequencing to identify the fraction of fastidious and anaerobic bacteria in clinical specimens that may not be recognized by routine laboratory urine culture methods (4, 7). Of the 1,449 urine specimens analyzed in their study, 37 samples were found to be culture negative and PCR positive (all of which were also positive for leukocyte esterase), compared to 128 culture-positive and PCR-positive samples. Numerous fastidious and anaerobic bacteria were identified, several of which are known to cause female genitourinary tract infections. What was of particular interest was the finding that approximately 16% of the culture-negative, PCR-positive urine samples contained Lactobacillus species as the sole microorganism whose genetic material could be recovered. Their study identified four different species of lactobacilli, Lactobacillus crispatus, L. gasseri, L. iners, and L. jensenii. This finding led the authors to suggest that certain lactobacilli maybe capable of causing urinary tract infections as opportunistic pathogens.

In conclusion, we report a case of a patient with recurrent urinary tract infections in which L. delbrueckii was determined to be the etiologic agent. This case illustrates that in select situations, Lactobacillus spp. should not be regarded as simply a contaminant but as an unlikely, yet significant, cause of urinary tract inflammation and symptoms in otherwise immunocompetent female patients.

Footnotes

Published ahead of print on 5 November 2008.

REFERENCES

  • 1.Cannon, J. P., T. A. Lee, J. T. Bolanos, and L. H. Danziger. 2005. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur. J. Clin. Microbiol. Infect. Dis. 2431-40. [DOI] [PubMed] [Google Scholar]
  • 2.Clinical and Laboratory Standards Institute. 2008. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; approved guideline MM18-A. Clinical and Laboratory Standards Institute, Wayne, PA.
  • 3.Dickgiesser, U., N. Weiss, and D. Fritsche. 1984. Lactobacillus gasseri as the cause of septic urinary infection. Infection 1214-16. [DOI] [PubMed] [Google Scholar]
  • 4.Domann, E., G. Hong, C. Imirzalioglu, S. Turschner, J. Kühle, C. Watzel, T. Hain, H. Hossain, and T. Chakraborty. 2003. Culture-independent identification of pathogenic bacteria and polymicrobial infections in the genitourinary tract of renal transplant recipients. J. Clin. Microbiol. 415500-5510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Falagas, M. E., G. I. Betsi, T. Tokas, and S. Athanasiou. 2006. Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies. Drugs 661253-1261. [DOI] [PubMed] [Google Scholar]
  • 6.Germond, J. E., L. Lapierre, M. Delley, B. Mollet, G. E. Felis, and F. Dellaglio. 2003. Evolution of the bacterial species Lactobacillus delbrueckii: a partial genomic study with reflections on prokaryotic species concept. Mol. Biol. Evol. 2093-104. [DOI] [PubMed] [Google Scholar]
  • 7.Imirzalioglu, C., T. Hain, T. Chakraborty, and E. Domann. 2008. Hidden pathogens uncovered: metagenomic analysis of urinary tract infections. Andrologia 4066-71. [DOI] [PubMed] [Google Scholar]
  • 8.Murray, P. R., E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller (ed.). 2007. Manual of clinical microbiology, 9th edition. ASM Press, Washington, DC.
  • 9.Senok, A. C., A. Y. Ismaeel, and G. A. Botta. 2005. Probiotics: facts and myths. Clin. Microbiol. Infect. 11958-966. [DOI] [PubMed] [Google Scholar]
  • 10.Velraeds, M. M., B. van de Belt-Gritter, H. C. van der Mei, G. Reid, and H. J. Busscher. 1998. Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. J. Med. Microbiol. 471081-1085. [DOI] [PubMed] [Google Scholar]
  • 11.Winn, W., Jr., S. Allen, W. Janda, E. Koneman, G. Procop, P. Schreckenberger, and G. Woods. 2006. Koneman's color atlas and textbook of diagnostic microbiology, 6th edition. Lippincott Williams & Wilkins, Baltimore, MD.

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES